Priyank Desai, MD
Pulmonary Disease · Rocky Mount, NCNPI 1316148794
Payments from drug & device makers
Across 616 payments — averaging $578.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$217K
- Chiesi USA, Inc.$41K
- Boehringer Ingelheim$32K
- AstraZeneca$31K
- Mylan Specialty L.p.$19K
- Sunovion Pharmaceuticals Inc.$8K
- plus $8K from 21 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 238 | $217,297 |
| Chiesi USA, Inc. | 14 | $41,204 |
| Boehringer Ingelheim | 88 | $31,514 |
| AstraZeneca | 82 | $31,041 |
| Mylan Specialty L.p. | 40 | $19,025 |
| Sunovion Pharmaceuticals Inc. | 38 | $7,908 |
| Viiv Healthcare Company | 4 | $4,341 |
| Mallinckrodt Hospital Products Inc. | 22 | $1,677 |
| Olympus Corporation Of The Americas | 13 | $1,318 |
| Amgen | 34 | $262 |
| Sanofi | 6 | $109 |
| Genentech USA, Inc. | 6 | $104 |
| Insmed, Inc. | 3 | $58 |
| Grifols USA, LLC | 3 | $58 |
| ANI Pharmaceuticals, Inc. | 2 | $53 |
| Novartis | 2 | $43 |
| Medtronic | 2 | $40 |
| United Therapeutics Corporation | 8 | $38 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| CSL Behring | 2 | $31 |
| Shionogi Inc | 1 | $20 |
| Breathe Technologies, Inc. | 1 | $19 |
| Inogen, Inc. | 1 | $17 |
| Verona Pharma, Inc. | 1 | $15 |
| Viatris Specialty LLC | 1 | $13 |
| Merck | 1 | $12 |
| Gilead | 1 | $12 |
How this compares
$356,267 in reported general payments places this provider in the 90th percentile of 393 pulmonary disease providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Rocky Mount
- Selwyn SpangenthalCharlotte$7M
- Thomas SternHuntersville$5.2M
- Laurie SnyderDurham$3.8M
- Scott PalmerDurham$3.8M
- Michael PritchettPinehurst$2.2M
- Anup BanerjeeGastonia$2.1M
- Hubert FordChapel Hill$2M
- Murali RamaswamyGreensboro$2M
- Mikell JarrattGastonia$1.7M
- Lake MorrisonDurham$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.